Iizuka A - Search Results

1

Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.

Kuwatani M, Ikarashi Y, Iizuka A, Kawakami C, Quinn G, Heike Y, Yoshida M, Asaka M, Takaue Y, Wakasugi H. Kuwatani M, et al. Among authors: iizuka a. Immunol Lett. 2006 Jul 15;106(1):82-90. doi: 10.1016/j.imlet.2006.05.001. Epub 2006 May 23. Immunol Lett. 2006. PMID: 16806496

2

Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.

Ikarashi Y, Iizuka A, Heike Y, Yoshida M, Takaue Y, Wakasugi H. Ikarashi Y, et al. Among authors: iizuka a. Immunol Lett. 2005 Nov 15;101(2):160-7. doi: 10.1016/j.imlet.2005.05.007. Immunol Lett. 2005. PMID: 16054231

3

Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.

Ikarashi Y, Iizuka A, Koshidaka Y, Heike Y, Takaue Y, Yoshida M, Kronenberg M, Wakasugi H. Ikarashi Y, et al. Among authors: iizuka a. Immunology. 2005 Sep;116(1):30-7. doi: 10.1111/j.1365-2567.2005.02193.x. Immunology. 2005. PMID: 16108815 Free PMC article.

4

Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-gamma and IL-4.

Iizuka A, Ikarashi Y, Yoshida M, Heike Y, Takeda K, Quinn G, Wakasugi H, Kitagawa M, Takaue Y. Iizuka A, et al. Immunology. 2008 Jan;123(1):100-7. doi: 10.1111/j.1365-2567.2007.02732.x. Epub 2007 Nov 14. Immunology. 2008. PMID: 18005033 Free PMC article.

5

Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.

Harada Y, Imataki O, Heike Y, Kawai H, Shimosaka A, Mori S, Kami M, Tanosaki R, Ikarashi Y, Iizuka A, Yoshida M, Wakasugi H, Saito S, Takaue Y, Takei M, Kakizoe T. Harada Y, et al. Among authors: iizuka a. J Immunother. 2005 Jul-Aug;28(4):314-21. doi: 10.1097/01.cji.0000163593.66910.ad. J Immunother. 2005. PMID: 16000949

6

Insufficient ex vivo expansion of Valpha24(+) natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14(+) cells.

Imataki O, Heike Y, Makiyama H, Iizuka A, Ikarashi Y, Ishida T, Wakasugi H, Takaue Y. Imataki O, et al. Among authors: iizuka a. Cytotherapy. 2008;10(5):497-506. doi: 10.1080/14653240802072747. Cytotherapy. 2008. PMID: 18608348

7

G2-phase arrest through p21(WAF1 / Cip1) induction and cdc2 repression by gnidimacrin in human hepatoma HLE cells.

Yoshida M, Matsui Y, Iizuka A, Ikarashi Y. Yoshida M, et al. Among authors: iizuka a. Anticancer Res. 2009 Apr;29(4):1349-54. Anticancer Res. 2009. PMID: 19414386 Free article.

8

Early full donor myeloid chimerism after reduced-intensity stem cell transplantation using a combination of fludarabine and busulfan.

Niiya H, Kanda Y, Saito T, Ohnishi T, Kanai S, Kawano Y, Kamijo K, Iizuka A, Yakushijin K, Ueda K, Chizuka A, Iijima K, Ohnishi M, Nakai K, Makimoto A, Tanosaki R, Tobinai K, Wakasugi H, Takaue Y, Mineishi S. Niiya H, et al. Among authors: iizuka a. Haematologica. 2001 Oct;86(10):1071-4. Haematologica. 2001. PMID: 11602413 Clinical Trial.

9

The anti-tumor activity of the STAT3 inhibitor STX-0119 occurs via promotion of tumor-infiltrating lymphocyte accumulation in temozolomide-resistant glioblastoma cell line.

Akiyama Y, Nonomura C, Ashizawa T, Iizuka A, Kondou R, Miyata H, Sugino T, Mitsuya K, Hayashi N, Nakasu Y, Asai A, Ito M, Kiyohara Y, Yamaguchi K. Akiyama Y, et al. Among authors: iizuka a. Immunol Lett. 2017 Oct;190:20-25. doi: 10.1016/j.imlet.2017.07.005. Epub 2017 Jul 15. Immunol Lett. 2017. PMID: 28716484

10

Impact of combination therapy with anti-PD-1 blockade and a STAT3 inhibitor on the tumor-infiltrating lymphocyte status.

Ashizawa T, Iizuka A, Maeda C, Tanaka E, Kondou R, Miyata H, Sugino T, Kawata T, Deguchi S, Mitsuya K, Hayashi N, Asai A, Ito M, Yamaguchi K, Akiyama Y. Ashizawa T, et al. Among authors: iizuka a. Immunol Lett. 2019 Dec;216:43-50. doi: 10.1016/j.imlet.2019.10.003. Epub 2019 Oct 3. Immunol Lett. 2019. PMID: 31586551 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters